Structural basis for potent antibody-mediated neutralization of human cytomegalovirus.
Chandramouli, S., Malito, E., Nguyen, T., Luisi, K., Donnarumma, D., Xing, Y., Norais, N., Yu, D., Carfi, A.(2017) Sci Immunol 2
- PubMed: 28783665
- DOI: https://doi.org/10.1126/sciimmunol.aan1457
- Primary Citation of Related Structures:
5VOB, 5VOC, 5VOD - PubMed Abstract:
Human cytomegalovirus (HCMV) is the leading viral cause of birth defects and organ transplant rejection. The HCMV gH/gL/UL128/UL130/UL131A complex (Pentamer) is the main target of humoral responses and thus a key vaccine candidate. We report two structures of Pentamer bound to human neutralizing antibodies, 8I21 and 9I6, at 3.0 and 5.9 Å resolution, respectively. The HCMV gH/gL architecture is similar to that of Epstein-Barr virus (EBV) except for amino-terminal extensions on both subunits. The extension of gL forms a subdomain composed of a three-helix bundle and a β hairpin that acts as a docking site for UL128/UL130/UL131A. Structural analysis reveals that Pentamer is a flexible molecule, and suggests sites for engineering stabilizing mutations. We also identify immunogenic surfaces important for cellular interactions by epitope mapping and functional assays. These results can guide the development of effective vaccines and immunotherapeutics against HCMV.
Organizational Affiliation:
GSK Vaccines, 14200 Shady Grove Road, Rockville, MD 20850, USA.